Intermediate endpoint biomarkers for chemoprevention
- 1 January 1992
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 50 (S16I), 93-110
- https://doi.org/10.1002/jcb.240501320
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Chemoprevention clinical trialsMutation Research, 1992
- Oncogene proteins as biomarkers in the molecular epidemiology of occupational carcinogenesisInternationales Archiv für Arbeitsmedizin, 1991
- Actin cytoskeletal network in aging and cancerMutation Research/DNAging, 1991
- Biomarkers as Intermediate End Points in Chemoprevention TrialsJNCI Journal of the National Cancer Institute, 1990
- A conceptual framework for the validation and use of biologic markersEnvironmental Research, 1989
- DNA hyperploidy as a marker for biological response to bladder carcinogen exposureInternational Journal of Cancer, 1988
- New Markers for Monitoring Occupational Cancer: The Example of Oncogene ProteinsJournal of Occupational and Environmental Medicine, 1988
- Quantitative fluorescence measurements of ao-stained normal and malignant bladder cellsInternational Journal of Cancer, 1983
- N-ACETYLTRANSFERASE PHENOTYPE AND RISK IN INDUSTRIAL URINARY BLADDER CANCER: APPROACHES TO HIGH RISK GROUPSPublished by Elsevier ,1979
- Detection of suspicious cells and rejection of artefacts in cervical cytology using the Leyden Television Analysis System.Journal of Histochemistry & Cytochemistry, 1979